 |
Dr. Pierre Escoubas is Associate Professor at the University of Nice-Sophia Antipolis and works at the Institute of Molecular and Cellular Pharmacology in Sophia-Antipolis. After a PhD in Chemical Entomology at Université Pierre et Marie Curie in Paris in 1988, he worked as a post-doctoral associate at the University of Georgia (USA) before moving to Japan as a research associate for the Japan Research and Development Corporation. In 1993, he joined the Suntory Institute for Bioorganic Research (SUNBOR) in Osaka to work on peptide toxins from animal venoms. He returned to France in 1998 to join the group of Prof. M. Lazdunski where he has been involved in ion channel pharmacology and the discovery of novel peptide toxins from various venomous animals, especially spiders. His research interests include the search for novel ligands of ion channels involved in nociception and the development of spider toxins as drug leads. Dr. Escoubas is a specialist of peptide / protein mass spectrometry. He is now co-founder and president of VenomeTech Inc., a biotechnology startup dedicated to the development of innovative drugs from animal venom peptides.
|